P3.12-05 the Pattern of PD-L1 Expression in Thoracic Neuroendocrine Tumors

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1828
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PD-L1 Expression in Inflammatory Myofibroblastic Tumors

Modern Pathology
Forensic MedicinePathology
2018English

P2.04-05 Correlation Between PD-L1 Gene Promoter Polymorphisms and Expression of PD-L1 mRNA and Protein in NSCLC Patients.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.09-05 Why Does PD-L1 (22C3) Expression Rate Show Difference Among Regional Hospitals?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.09-05 Significance of the Expression of PD-L1/PD-1 by Tumoral and Immune Cells in Non-Small Cell Lung Cancer.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

The Expression of PD-L1 in Salivary Gland Carcinomas

Scientific Reports
Multidisciplinary
2019English

P1.12-05 Efficacy of Perioperative Chemotherapy for High-Grade Neuroendocrine Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors

Scientific Reports
Multidisciplinary
2017English

Tumor-Infiltrating T Cells and PD-L1 Expression in Childhood Malignant Extracranial Germ-Cell Tumors

OncoImmunology
OncologyAllergyImmunology
2018English

PD-L1 Expression in Triple-Negative Breast Cancer

Cancer immunology research
Cancer ResearchImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy